News
Cellarity, along with Flagship Pioneering and its portfolio companies, make news because of their transformative approaches to solving global challenges. For further information, please contact press@cellarity.com.
In the News
-
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
02.25.2021
-
Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
07.16.2020
-
Flagship Pioneering launches Cellarity for cell behaviour-targeting drugs
12.11.2019
-
Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics
12.11.2019
-
Flagship’s Cellarity maps out network-based drug discovery
12.10.2019
-
Flagship Pioneering Launches New Company to Discover Medicines Targeting Cellular Behavior | BioSpace
12.10.2019
-
Flagship Pioneering's Cellarity Exits Stealth Mode to Discover Drugs Using Cell Behavior
12.10.2019
-
Cellarity, Flagship's $50M bet on Network Biology, Marries Machine Learning and Single-Cell Tech for Drug Discovery
12.10.2019
-
Fierce Biotech | Flagship Company Cellarity Takes Aim at Cell Behavior
12.10.2019
-
Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior
12.09.2019
-
Can Machines Understand Complex Biology?
10.22.2019